Flores-Clemente et al., 2021 - Google Patents
Inhibition of astrocytic histamine n-methyltransferase as a possible target for the treatment of Alzheimer's diseaseFlores-Clemente et al., 2021
View HTML- Document ID
- 6938621439435854200
- Author
- Flores-Clemente C
- Nicolás-Vázquez M
- Mera Jiménez E
- Hernández-Rodríguez M
- Publication year
- Publication venue
- Biomolecules
External Links
Snippet
Alzheimer's disease (AD) represents the principal cause of dementia among the elderly. Great efforts have been established to understand the physiopathology of AD. Changes in neurotransmitter systems in patients with AD, including cholinergic, GABAergic …
- 206010001897 Alzheimer's disease 0 title abstract description 131
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Al Ojaimi et al. | Mitochondrial fission and fusion: molecular mechanisms, biological functions, and related disorders | |
| Virtanen et al. | NKCC1, an elusive molecular target in brain development: making sense of the existing data | |
| Tiapko et al. | TRPC3 as a target of novel therapeutic interventions | |
| Franco et al. | Adenosine A2A receptor antagonists affects NMDA glutamate receptor function. Potential to address neurodegeneration in Alzheimer’s disease | |
| Flores-Clemente et al. | Inhibition of astrocytic histamine n-methyltransferase as a possible target for the treatment of Alzheimer’s disease | |
| Eissa et al. | The dual-active histamine H3 receptor antagonist and acetylcholine esterase inhibitor E100 alleviates autistic-like behaviors and oxidative stress in valproic acid induced autism in mice | |
| Musheshe et al. | Pharmacological inhibition of Epac1 averts ferroptosis cell death by preserving mitochondrial integrity | |
| Evans et al. | New insights into mechanisms and functions of chemokine (CXC motif) receptor 4 heteromerization in vascular smooth muscle | |
| Ramos-Molina et al. | Antizyme inhibitors in polyamine metabolism and beyond: physiopathological implications | |
| Navarrete et al. | CB2 receptor involvement in the treatment of substance use disorders | |
| Kawahata et al. | Dopamine D1–D5 receptors in brain nuclei: Implications for health and disease | |
| Pittaluga et al. | Somatostatin, a presynaptic modulator of glutamatergic signal in the central nervous system | |
| Han et al. | Inhibiting NLRP3 inflammasome activation by CY-09 helps to restore cerebral glucose metabolism in 3× Tg-AD mice | |
| Campanari et al. | TDP-43 regulation of AChE expression can mediate ALS-like phenotype in zebrafish | |
| Yerna et al. | Role of the TRPC1 channel in hippocampal long-term depression and in spatial memory extinction | |
| Perni | The builders of the junction: roles of junctophilin1 and junctophilin2 in the assembly of the sarcoplasmic reticulum–plasma membrane junctions in striated muscle | |
| Peggion et al. | Regulation of Endoplasmic Reticulum–Mitochondria Tethering and Ca2+ Fluxes by TDP-43 via GSK3β | |
| Raïch et al. | Antagonization of OX1 receptor potentiates CB2 receptor function in microglia from APPSw/Ind mice model | |
| Lee et al. | The natural alkaloid palmatine selectively induces mitophagy and restores mitochondrial function in an Alzheimer’s disease mouse model | |
| Santos et al. | Modeling autism spectrum disorders with induced pluripotent stem cell-derived brain organoids | |
| Zernov et al. | New positive TRPC6 modulator penetrates blood–brain barrier, eliminates synaptic Deficiency and restores memory deficit in 5xFAD mice | |
| Yang et al. | Histone lactylation is involved in mouse oocyte maturation and embryo development | |
| Oleksak et al. | Neuropharmacology of cevimeline and muscarinic drugs—focus on cognition and neurodegeneration | |
| Hassan et al. | A link between mitochondrial dysregulation and idiopathic autism spectrum disorder (ASD): alterations in mitochondrial respiratory capacity and membrane potential | |
| Reid et al. | Loss-of-function variants in DRD1 in infantile Parkinsonism-dystonia |